| Symbol |
Name |
Standardized Value |
|
CD1A
|
CD1a molecule
|
4.0
|
|
CD1E
|
CD1e molecule
|
4.0
|
|
CD1B
|
CD1b molecule
|
4.0
|
|
CD1C
|
CD1c molecule
|
4.0
|
|
CD1D
|
CD1d molecule
|
3.98
|
|
CD207
|
CD207 molecule, langerin
|
3.823
|
|
CD68
|
CD68 molecule
|
3.476
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
3.307
|
|
CD163
|
CD163 molecule
|
2.867
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
2.863
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
2.759
|
|
SLC29A3
|
solute carrier family 29 (equilibrative nucleoside transporter), member 3
|
2.709
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
2.457
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
2.426
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
2.401
|
|
CD34
|
CD34 molecule
|
2.364
|
|
FSCN1
|
fascin actin-bundling protein 1
|
2.36
|
|
IFNA17
|
interferon, alpha 17
|
2.329
|
|
IFNA7
|
interferon, alpha 7
|
2.325
|
|
IFNA5
|
interferon, alpha 5
|
2.323
|
|
IFNA16
|
interferon, alpha 16
|
2.321
|
|
IFNA21
|
interferon, alpha 21
|
2.32
|
|
IFNA14
|
interferon, alpha 14
|
2.32
|
|
IFNA6
|
interferon, alpha 6
|
2.32
|
|
IFNA10
|
interferon, alpha 10
|
2.32
|
|
IFNA8
|
interferon, alpha 8
|
2.32
|
|
IFNA4
|
interferon, alpha 4
|
2.318
|
|
IFNA13
|
interferon, alpha 13
|
2.317
|
|
IFNA1
|
interferon, alpha 1
|
2.304
|
|
IFNA2
|
interferon, alpha 2
|
2.303
|
|
CD4
|
CD4 molecule
|
2.235
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
2.205
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
2.19
|
|
NF1
|
neurofibromin 1
|
2.188
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.169
|
|
PGM1
|
phosphoglucomutase 1
|
2.148
|
|
KIF5B
|
kinesin family member 5B
|
2.133
|
|
ETV3
|
ets variant 3
|
2.132
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
2.128
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
2.12
|
|
CD8A
|
CD8a molecule
|
2.098
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
2.08
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
2.058
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
2.056
|
|
S100A9
|
S100 calcium binding protein A9
|
2.053
|
|
FLCN
|
folliculin
|
2.04
|
|
STX11
|
syntaxin 11
|
2.02
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
1.97
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.961
|
|
TNF
|
tumor necrosis factor
|
1.946
|
|
CD5
|
CD5 molecule
|
1.945
|
|
STXBP2
|
syntaxin binding protein 2
|
1.929
|
|
PAX5
|
paired box 5
|
1.926
|
|
IL6
|
interleukin 6
|
1.923
|
|
IFNG
|
interferon, gamma
|
1.915
|
|
SDC1
|
syndecan 1
|
1.909
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
1.905
|
|
AVP
|
arginine vasopressin
|
1.896
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
1.876
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.868
|
|
IL1B
|
interleukin 1, beta
|
1.868
|
|
MPO
|
myeloperoxidase
|
1.861
|
|
SPN
|
sialophorin
|
1.861
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.849
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
1.837
|
|
IL1A
|
interleukin 1, alpha
|
1.818
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.808
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
1.799
|
|
POMC
|
proopiomelanocortin
|
1.792
|
|
CD19
|
CD19 molecule
|
1.766
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
1.765
|
|
VEGFD
|
vascular endothelial growth factor D
|
1.76
|
|
PRL
|
prolactin
|
1.756
|
|
MME
|
membrane metallo-endopeptidase
|
1.749
|
|
CD2
|
CD2 molecule
|
1.746
|
|
CD99
|
CD99 molecule
|
1.741
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.738
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.732
|
|
TP53
|
tumor protein p53
|
1.73
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
1.729
|
|
IL10
|
interleukin 10
|
1.709
|
|
MIGA1
|
mitoguardin 1
|
1.701
|
|
ALB
|
albumin
|
1.698
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.693
|
|
CCND1
|
cyclin D1
|
1.693
|
|
SH2D1A
|
SH2 domain containing 1A
|
1.691
|
|
CD7
|
CD7 molecule
|
1.691
|
|
CD38
|
CD38 molecule
|
1.688
|
|
CD99L2
|
CD99 molecule-like 2
|
1.68
|
|
CD33
|
CD33 molecule
|
1.667
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
1.664
|
|
PRF1
|
perforin 1 (pore forming protein)
|
1.661
|
|
IL2
|
interleukin 2
|
1.651
|
|
IL4
|
interleukin 4
|
1.642
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.632
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.63
|
|
IL17A
|
interleukin 17A
|
1.625
|
|
CD83
|
CD83 molecule
|
1.597
|
|
LYST
|
lysosomal trafficking regulator
|
1.586
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
1.585
|
|
RPH3A
|
rabphilin 3A
|
1.578
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.578
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
1.575
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.574
|
|
ACE
|
angiotensin I converting enzyme
|
1.57
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
1.57
|
|
EWSR1
|
EWS RNA-binding protein 1
|
1.561
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
1.555
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
1.544
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
1.53
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.529
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.527
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
1.525
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
1.523
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.521
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.52
|
|
NCOA2
|
nuclear receptor coactivator 2
|
1.517
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.514
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.511
|
|
AFP
|
alpha-fetoprotein
|
1.504
|
|
RNF11
|
ring finger protein 11
|
1.503
|
|
EGFR
|
epidermal growth factor receptor
|
1.502
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.502
|
|
TSC2
|
tuberous sclerosis 2
|
1.498
|
|
MYOG
|
myogenin (myogenic factor 4)
|
1.498
|
|
FLT3
|
fms-related tyrosine kinase 3
|
1.491
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
1.487
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
1.483
|
|
SYP
|
synaptophysin
|
1.48
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
1.473
|
|
CD274
|
CD274 molecule
|
1.468
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
1.457
|
|
IL3
|
interleukin 3
|
1.454
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
1.452
|
|
RET
|
ret proto-oncogene
|
1.451
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.449
|
|
KRT7
|
keratin 7, type II
|
1.446
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
1.44
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
1.434
|
|
KIAA1549
|
KIAA1549
|
1.434
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
1.433
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
1.422
|
|
B2M
|
beta-2-microglobulin
|
1.419
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.419
|
|
ETV6
|
ets variant 6
|
1.416
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
1.413
|
|
ZBTB46
|
zinc finger and BTB domain containing 46
|
1.409
|
|
TPM3
|
tropomyosin 3
|
1.407
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
1.407
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.4
|
|
PRTN3
|
proteinase 3
|
1.399
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
1.395
|
|
PDPN
|
podoplanin
|
1.391
|
|
JAK2
|
Janus kinase 2
|
1.39
|
|
IL18
|
interleukin 18
|
1.382
|
|
CD52
|
CD52 molecule
|
1.382
|
|
PTEN
|
phosphatase and tensin homolog
|
1.38
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
1.376
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.375
|
|
ALPP
|
alkaline phosphatase, placental
|
1.374
|
|
MYOM2
|
myomesin 2
|
1.37
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.369
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.369
|
|
MSR1
|
macrophage scavenger receptor 1
|
1.359
|
|
IL5
|
interleukin 5
|
1.355
|
|
SPP1
|
secreted phosphoprotein 1
|
1.352
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.352
|
|
CD22
|
CD22 molecule
|
1.351
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
1.346
|
|
F2
|
coagulation factor II (thrombin)
|
1.341
|
|
ACR
|
acrosin
|
1.339
|
|
CD86
|
CD86 molecule
|
1.337
|
|
FOXP3
|
forkhead box P3
|
1.33
|
|
GFAP
|
glial fibrillary acidic protein
|
1.328
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.328
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
1.322
|
|
NF2
|
neurofibromin 2 (merlin)
|
1.32
|
|
CD40LG
|
CD40 ligand
|
1.318
|
|
SFTPC
|
surfactant protein C
|
1.317
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.31
|
|
WT1
|
Wilms tumor 1
|
1.309
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.306
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.302
|
|
IL13
|
interleukin 13
|
1.3
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.295
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
1.295
|
|
OAT
|
ornithine aminotransferase
|
1.29
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
1.288
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
1.288
|
|
CPQ
|
carboxypeptidase Q
|
1.285
|
|
AIF1
|
allograft inflammatory factor 1
|
1.284
|
|
PTH
|
parathyroid hormone
|
1.278
|
|
DNTT
|
DNA nucleotidylexotransferase
|
1.273
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.273
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
1.271
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
1.271
|
|
PXDN
|
peroxidasin
|
1.269
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.268
|
|
PXDNL
|
peroxidasin-like
|
1.266
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
1.262
|
|
STX19
|
syntaxin 19
|
1.262
|
|
SPI1
|
Spi-1 proto-oncogene
|
1.243
|
|
IRF4
|
interferon regulatory factor 4
|
1.241
|
|
MITF
|
microphthalmia-associated transcription factor
|
1.236
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
1.234
|
|
PROP1
|
PROP paired-like homeobox 1
|
1.233
|
|
CD80
|
CD80 molecule
|
1.233
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
1.228
|
|
CLTC
|
clathrin, heavy chain (Hc)
|
1.228
|
|
TRH
|
thyrotropin-releasing hormone
|
1.226
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
1.223
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
1.222
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.22
|
|
BCR
|
breakpoint cluster region
|
1.218
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
1.217
|
|
TERT
|
telomerase reverse transcriptase
|
1.214
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
1.214
|
|
KRT20
|
keratin 20, type I
|
1.214
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
1.208
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
1.206
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
1.205
|
|
TBX19
|
T-box 19
|
1.204
|
|
IL7
|
interleukin 7
|
1.204
|
|
RUNX1
|
runt-related transcription factor 1
|
1.204
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.197
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
1.195
|
|
CLEC4C
|
C-type lectin domain family 4, member C
|
1.194
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.193
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
1.191
|
|
IFNGR1
|
interferon gamma receptor 1
|
1.189
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.187
|
|
PDCD1
|
programmed cell death 1
|
1.184
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.183
|
|
CTSK
|
cathepsin K
|
1.182
|
|
CD27
|
CD27 molecule
|
1.181
|
|
LPIN2
|
lipin 2
|
1.18
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.179
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
1.173
|
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
1.168
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
1.163
|
|
AR
|
androgen receptor
|
1.159
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
1.155
|
|
ITGAD
|
integrin, alpha D
|
1.151
|
|
NKX2-1
|
NK2 homeobox 1
|
1.148
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
1.145
|
|
NOTCH1
|
notch 1
|
1.144
|
|
SALL4
|
spalt-like transcription factor 4
|
1.144
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.143
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
1.142
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
1.142
|
|
AGAP3
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3
|
1.14
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.138
|
|
AP3B1
|
adaptor-related protein complex 3, beta 1 subunit
|
1.138
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
1.137
|
|
MB
|
myoglobin
|
1.137
|
|
LMNA
|
lamin A/C
|
1.134
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.134
|
|
MUC1
|
mucin 1, cell surface associated
|
1.133
|
|
INS
|
insulin
|
1.121
|
|
HP
|
haptoglobin
|
1.118
|
|
PSMA7
|
proteasome (prosome, macropain) subunit, alpha type, 7
|
1.117
|
|
SETBP1
|
SET binding protein 1
|
1.115
|
|
GHRH
|
growth hormone releasing hormone
|
1.115
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
1.112
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.111
|
|
BATF3
|
basic leucine zipper transcription factor, ATF-like 3
|
1.107
|
|
FAS
|
Fas cell surface death receptor
|
1.098
|
|
GATA2
|
GATA binding protein 2
|
1.096
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
1.091
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.09
|
|
TG
|
thyroglobulin
|
1.087
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
1.084
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
1.084
|
|
TSC1
|
tuberous sclerosis 1
|
1.082
|
|
MAN2C1
|
mannosidase, alpha, class 2C, member 1
|
1.082
|
|
LY75
|
lymphocyte antigen 75
|
1.081
|
|
LY75-CD302
|
LY75-CD302 readthrough
|
1.079
|
|
KITLG
|
KIT ligand
|
1.078
|
|
CALB2
|
calbindin 2
|
1.075
|
|
JAG2
|
jagged 2
|
1.073
|
|
BCL2L1
|
BCL2-like 1
|
1.071
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
1.069
|
|
JAK3
|
Janus kinase 3
|
1.068
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
1.068
|
|
SIGLEC1
|
sialic acid binding Ig-like lectin 1, sialoadhesin
|
1.067
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.058
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
1.055
|
|
STAB1
|
stabilin 1
|
1.055
|
|
CALR
|
calreticulin
|
1.055
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
1.051
|
|
IGLON5
|
IgLON family member 5
|
1.051
|
|
CKM
|
creatine kinase, muscle
|
1.047
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
1.047
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
1.046
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
1.044
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.043
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.042
|
|
CKB
|
creatine kinase, brain
|
1.039
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
1.037
|
|
MYOD1
|
myogenic differentiation 1
|
1.033
|
|
CDK4
|
cyclin-dependent kinase 4
|
1.031
|
|
CD209
|
CD209 molecule
|
1.031
|
|
USP6
|
ubiquitin specific peptidase 6
|
1.03
|
|
GNAS
|
GNAS complex locus
|
1.029
|
|
CD58
|
CD58 molecule
|
1.028
|
|
MAP3K15
|
mitogen-activated protein kinase kinase kinase 15
|
1.028
|
|
TLR7
|
toll-like receptor 7
|
1.028
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
1.02
|
|
NLRC4
|
NLR family, CARD domain containing 4
|
1.019
|
|
PSTPIP2
|
proline-serine-threonine phosphatase interacting protein 2
|
1.019
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
1.016
|
|
IRF8
|
interferon regulatory factor 8
|
1.015
|
|
MMP12
|
matrix metallopeptidase 12
|
1.01
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
1.008
|
|
ENTPD2
|
ectonucleoside triphosphate diphosphohydrolase 2
|
1.005
|
|
KRT5
|
keratin 5, type II
|
1.004
|
|
PAX8
|
paired box 8
|
1.002
|
